ArticleFrontiers in immunology2022

Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project.

Valéria Valim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.